We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




SARS Case Confirmed in China

By HospiMedica staff writers
Posted on 13 Jan 2004
Results of laboratory tests have confirmed a case of severe acute respiratory syndrome (SARS) in a 32-year-old man in the Chinese province of Guangdong.

The patient has been under treatment, in isolation, since December 20, 2003, and is reported to be recovering. More...
This is the first confirmed case of SARS in 2004 and the first not linked to a laboratory accident, as were several cases in Singapore and Taiwan in 2003. The source of infection in the newly confirmed case remains unclear. All contacts have been traced and are reported to be free of symptoms and most have been released from quarantine. Surveillance for additional cases has been intensified in Guangdong and other provinces.

Studies conducted in 2003 detected a SARS-like virus in some animal species, including the masked palm civet, and a retrospective analysis of patient records has linked several early cases to contact with wild animals. As a result, the government of Guandong is moving to eradicate the civet cat, a popular food item. Still, no animal reservoir of the SARS coronavirus has been conclusively identified to date.

The confirmatory tests were conducted in Hong Kong by the University of Hong Kong and the government Virus Unit of the Department of Health. Both are members of the World Health Organization (WHO, Geneva, Switzerland; www.who.int) Multicenter Collaborative Network for SARS Diagnosis that collectively identified the SARS coronavirus in mid-April 2003. Confirmation of positive results by a WHO-designated reference laboratory is required for a definitive diagnosis of SARS.

The first cases of SARS occurred in Guangdong in mid-November 2002. The disease spread internationally, eventually causing more than 8,000 cases and 774 deaths in 27 countries.




Related Links:
WHO

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.